Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSIST-IT2: Intravenous Tirofiban Before Endovascular Thrombectomy for Ischemic Stroke
NCT07135089Phase 3Recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Nov 2025
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tirofiban in ischemic stroke, sponsored by General Hospital of the Northern Theater Command. Started Nov 2025; status: recruiting.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07135089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07135089.